October 12, 2020 | by Zachary Halaschak, Breaking News Reporter | Washington Examiner |
“A coronavirus vaccine study by Johnson & Johnson has been put on pause after one of the study’s participants had an “unexpected illness.”
An independent safety monitoring board will review the patient’s case as will internal clinical and safety physicians, the company said in a Monday evening news release.
“Adverse events — illnesses, accidents, etc. — even those that are serious, are an expected part of any clinical study, especially large studies,” Johnson & Johnson said, adding that the company has guidelines for unexpected serious adverse events that can put studies on pause while they are being investigated.”